Gov. Phil Murphy suggested that fewer people are willing to get inoculated because of mindsets such as, “the weather’s getting warmer, the numbers are going in the right direction, I feel good, I haven’t gotten sick yet.” And added, “Those are not [good] reasons. We need folks to get vaccinated.”

The Kenilworth-based drugmaker set a goal to achieve 100% renewable energy 15 years ahead of schedule, which includes three new virtual power purchase agreements.

Peter Kaprielyan will lead fundraising and philanthropic initiatives while maintaining his position as vice president for Government and External Affairs for the system.

The Bridgewater-based pharmaceutical company is the only one that has leveraged its manufacturing capacity to produce three different inoculations to address the pandemic and support the global supply of vaccines.

According to New Jersey Health Commissioner Judith Persichilli, sites were notified beginning April 23 that they could start using the shots following a decision from the CDC earlier in the day.

The CEO of Penn Medicine Princeton Health talks about taking on the top job at a prominent health care system during the pandemic, his priorities for the future and the Plainsboro-based system's expansion plans.

In recognition of the $4 million pledge, the largest in the organization's history, a newly planned outpatient center will be named the Englewood Health ZT Systems Outpatient Center at Jersey City.

The grant is the largest single commitment in the hospital’s 121-year history and will help support the renovation of its emergency department.

Two facilities broke into the global top 200 list, while Valley Hospital, Overlook Medical Center and Newark Beth Israel Medical Center were named among the top in the U.S.

The cash donation builds on the Franklin Lakes-based medical technology company's relationship with UNICEF that was established in 1997.

Nelson Ambrogio and John Berrios will serve on the U.S. Pharmaceutical Leadership Team and report directly to the sector's Americas Region President Sebastian Guth.

The New Brunswick drugmaker's first-quarter income grew from nearly $5.8 billion in 2020 to $6.2 billion in 2021.